rs80338732
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_002764.4(PRPS1):c.344T>C(p.Met115Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M115V) has been classified as Likely pathogenic.
Frequency
Consequence
NM_002764.4 missense
Scores
Clinical Significance
Conservation
Publications
- Arts syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia
- Charcot-Marie-Tooth disease X-linked recessive 5Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet, G2P
- hearing loss, X-linked 1Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia
- phosphoribosylpyrophosphate synthetase superactivityInheritance: XL Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen
- PRPS1 deficiency disorderInheritance: XL Classification: DEFINITIVE Submitted by: Illumina, ClinGen
- mild phosphoribosylpyrophosphate synthetase superactivityInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- severe phosphoribosylpyrophosphate synthetase superactivityInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- X-linked intellectual disability-limb spasticity-retinal dystrophy-diabetes insipidus syndromeInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- X-linked nonsyndromic hearing lossInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease X-linked recessive 5 Pathogenic:2Other:1
- -
- -
The variant is not observed in the gnomAD v2.1.1 dataset. Predicted Consequence/Location: Missense changes are a common disease-causing mechanism. Functional studies provide moderate evidence of the variant having a damaging effect on the gene or gene product (PMID: 17701900, 33493137). In silico tool predictions suggest damaging effect of the variant on gene or gene product [REVEL: 0.89 (>=0.6, sensitivity 0.68 and specificity 0.92); 3Cnet: 0.93 (>=0.6, sensitivity 0.72 and precision 0.9)]. Same nucleotide change resulting in same amino acid change has been previously reported to be associated with PRPS1 related disorder (ClinVar ID: VCV000009935 /PMID: 17701900).A different missense change at the same codon (p.Met115Val) has been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000140572 /PMID: 25182139). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. -
Charcot-Marie-Tooth Neuropathy X Pathogenic:1
This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 115 of the PRPS1 protein (p.Met115Thr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with X-linked recessive Charcot-Marie-Tooth disease-5 (CMTX5) (PMID: 17701900). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 9935). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PRPS1 protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects PRPS1 function (PMID: 17701900, 33493137). This variant disrupts the p.Met115 amino acid residue in PRPS1. Other variant(s) that disrupt this residue have been observed in individuals with PRPS1-related conditions (PMID: 25182139), which suggests that this may be a clinically significant amino acid residue. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at